Ivermectin is an antiparasitic medication that is used to treat a variety of parasitic infections in humans and animals. It is also being investigated for its potential use in the treatment of COVID-19.
What does the research say?
There have been a number of studies that have investigated the effectiveness of Ivermectin For Sale against COVID-19. However, the quality of these studies has been variable, and the results have been inconclusive.
Some studies have shown that ivermectin may be effective in reducing the severity of COVID-19 symptoms, while others have not found any benefit. For example, a 2021 study published in the American Journal of Therapeutics found that ivermectin was associated with a 93% reduction in the risk of hospitalization for COVID-19. However, a 2022 study published in The Lancet found that ivermectin did not reduce the risk of hospitalization or death from COVID-19.
What is the consensus?
The consensus among health experts is that there is not enough evidence to recommend ivermectin for the treatment of COVID-19. The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) both recommend against the use of ivermectin for the treatment of COVID-19.